InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: None

Tuesday, 02/27/2018 12:50:26 PM

Tuesday, February 27, 2018 12:50:26 PM

Post# of 402517
Pro-drugs are cute but not abuse deterrent





Example: KemPharm's Apadaz (prodrug of Norco). Received FDA approval last week after initially getting CRL due to lack of snorting abuse-resistance. As far as I can tell, the approval was given without any modification, but there is no ADF label. Unless they can figure out a market niche for a very expensive version of Norco without an ADF label, all they have is a new Oxaydo (no commercial viability).


Like most pro-drugs, Apadaz has some inherent overdose protection. Kempharm's studies show that there is a decrease in plasma concentration when *EIGHT* (8!!!) tablets are taken. In other words, not much help. Prodrugs are very finicky. Don't believe anything you hear until the data is available to prove it.









Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News